Evidence map›Paper›PMID 32820597›Full record

ArticleJournal of the International AIDS Society2020

Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya.

Valentine Wanga, Victor Omollo, Elizabeth A Bukusi, Josephine B Odoyo, Jennifer F Morton, Lara Kidoguchi, Rachel Johnson, James P Hughes, Connie Celum, Jared M Baeten

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. "AIDS care · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Valentine WangaDepartment of Epidemiology, University of Washington, Seattle, WA, USA.ORCID 0000-0002-9104-0125
Victor OmolloCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Elizabeth A BukusiDepartment of Global Health, University of Washington, Seattle, WA, USA.
Josephine B OdoyoCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Jennifer F MortonDepartment of Global Health, University of Washington, Seattle, WA, USA.
Lara KidoguchiDepartment of Global Health, University of Washington, Seattle, WA, USA.
Rachel JohnsonDepartment of Global Health, University of Washington, Seattle, WA, USA.
James P HughesDepartment of Biostatistics, University of Washington, Seattle, WA, USA.
Connie CelumDepartment of Global Health, University of Washington, Seattle, WA, USA.ORCID 0000-0002-8813-3419
Jared M BaetenDepartment of Epidemiology, University of Washington, Seattle, WA, USA.ORCID 0000-0001-8242-8438
University of Washington · USKenya Medical Research Institute · KE

Funding

PEPFAR
6 · The paper itself

Abstract

introductionHIV testing is a required part of delivery of pre-exposure prophylaxis (PrEP) for HIV prevention. However, repeat testing can be challenging in busy, under-staffed clinical settings, which could negatively impact PrEP uptake and continuation. We prospectively evaluated optional facility-based HIV self-testing (HIVST) among young women using PrEP in an implementation programme.

methodsBetween February and November 2019, we collected data from young women receiving PrEP at two family planning facilities in Kisumu, Kenya. At each PrEP follow-up visit, women were given the option to choose between provider-initiated testing and HIVST. We assessed factors associated with HIVST uptake and compared satisfaction with HIV testing and clinic experience between acceptors and decliners of HIVST.

resultsA total of 172 women were offered HIVST at 202 PrEP follow-up visits. The median age was 21 years, 27% had multiple partners and 15% reported previously using HIVST. HIVST was accepted at 34.7% (70/202) of visits. Age (adjusted relative risk (aRR) 1.09 per year, 95% CI (confidence interval) 1.01 to 1.18), never being married (aRR 1.81, 95% CI 1.11 to 2.95) and having more PrEP follow-up visits (aRR 1.13 per visit, 95% CI 1.04 to 1.23) were associated with HIVST uptake. Compared to HIVST decliners, HIVST acceptors were more likely to be very happy with their overall testing experience (73% vs. 47% of visits, p = 0.003) and were more likely to say they would use HIVST in the future (96% vs. 76%, p < 0.001). Women who accepted HIVST had shorter visits than those choosing standard provider-initiated HIV testing (median [IQR]: 33 [32, 38] vs. 54 [41.5, 81] minutes, p = 0.003).

conclusionsIn this pilot evaluation in Kenya, about one-third of women using PrEP opted for HIVST over provider-initiated testing, and those choosing HIVST spent less time in the clinic and were generally satisfied with their experience. HIVST in PrEP delivery is feasible and has the potential to simplify PrEP delivery and give clients testing autonomy. Additional studies are needed to explore optimal HIV retesting strategies in PrEP delivery, including the use of HIVST in PrEP at a larger scale and in different settings.

Indexed as

Ambulatory Care FacilitiesPre-Exposure ProphylaxisSelf-TestingAdolescentAdultAnti-HIV AgentsFamily Planning ServicesFemaleHIV InfectionsHumansKenyaPilot ProjectsProspective StudiesYoung AdultAnti-HIV AgentscounsellingHIV testingPrEPsatisfactionself-testingstandard of care

Identifiers

PMID32820597
PMCPMC7441009
OpenAlexW3081064757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.